{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:58:45Z","timestamp":1791939525171,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"a grant from Dainippon Sumitomo Pharma Co. Ltd"},{"DOI":"10.13039\/501100006453","name":"a grant from Taisho Toyama Pharmaceutical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"a Grant-in-Aid for Scientific Research","award":["21591294"],"award-info":[{"award-number":["21591294"]}]},{"name":"a Grant-in-Aid for Young Scientists (B)","award":["23791137"],"award-info":[{"award-number":["23791137"]}]},{"name":"a Grant-in-Aid for Young Scientists (B)","award":["25860830"],"award-info":[{"award-number":["25860830"]}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/1469-0691.12677","type":"journal-article","created":{"date-parts":[[2014,5,11]],"date-time":"2014-05-11T07:28:37Z","timestamp":1399793317000},"page":"O831-O839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae"],"prefix":"10.1016","volume":"20","author":[{"given":"Y.","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Morinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12677_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/420816","article-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended\u2010spectrum beta\u2010lactamases","volume":"39","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-12-245","article-title":"Impact of empirical treatment in extended\u2010spectrum beta\u2010lactamase\u2010producing Escherichia coli and Klebsiella spp. Bacteremia. A multicentric cohort study","volume":"12","author":"Peralta","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.50.2.498-504.2006","article-title":"Bloodstream infections caused by extended\u2010spectrum\u2010beta\u2010lactamase\u2010producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome","volume":"50","author":"Tumbarello","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-4453(90)92258-M","article-title":"Klebsiella pneumoniae bacteraemia at an urban general hospital","volume":"20","author":"Feldman","year":"1990","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12677_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0195-6701(98)90065-2","article-title":"Epidemiology of klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control","volume":"38","author":"Hansen","year":"1998","journal-title":"J Hosp Infect"},{"key":"10.1111\/1469-0691.12677_bib6","series-title":"Performance standards for antimicrobial susceptibility testing. M100\u2010s21","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1111\/1469-0691.12677_bib7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/jcm.25.8.1576-1578.1987","article-title":"Effect of inoculum size on results of macrotube broth dilution susceptibility tests with branhamella catarrhalis","volume":"25","author":"Doern","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12677_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/AAC.16.4.510","article-title":"Effect of inoculum size on the susceptibility of haemophilus influenzae b to beta\u2010lactam antibiotics","volume":"16","author":"Syriopoulou","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","article-title":"Inoculum effect","volume":"11","author":"Brook","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/AAC.35.9.1868","article-title":"Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta\u2010lactamase inhibitors and their penicillin\u2010derived components on the bacteroides fragilis group","volume":"35","author":"Goldstein","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01691969","article-title":"Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, haemophilus influenzae, and neisseria meningitidis","volume":"15","author":"Soriano","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib12","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to enterobacteriaceae producing extended\u2010spectrum beta\u2010lactamases: a systematic review and meta\u2010analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12677_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diagmicrobio.2004.07.006","article-title":"The inoculum effect: fact or artifact?","volume":"50","author":"Craig","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/cir793","article-title":"Can we really use ss\u2010lactam\/ss\u2010lactam inhibitor combinations for the treatment of infections caused by extended\u2010spectrum ss\u2010lactamase\u2010producing bacteria?","volume":"54","author":"Perez","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/AAC.38.2.195","article-title":"Different ratios of the piperacillin\u2010tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the tem\u20103 extended\u2010spectrum beta\u2010lactamase","volume":"38","author":"Leleu","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib16","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin\u2010tazobactam, and the inoculum effect in tests with extended\u2010spectrum beta\u2010lactamase\u2010producing enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijantimicag.2003.10.011","article-title":"Antimicrobial susceptibility of clinical isolates of enterobacteriaceae producing complex beta\u2010lactamase patterns including extended\u2010spectrum enzymes","volume":"23","author":"Segatore","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12677_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.42.1.269-275.2004","article-title":"Effects of inoculum and beta\u2010lactamase activity in ampc\u2010 and extended\u2010spectrum beta\u2010lactamase (esbl)\u2010producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using nccls esbl methodology","volume":"42","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12677_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2003.11.007","article-title":"In vitro killing of parenteral beta\u2010lactams against standard and high inocula of extended\u2010spectrum beta\u2010lactamase and non\u2010esbl producing Klebsiella pneumoniae","volume":"49","author":"Burgess","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib20","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.02190-12","article-title":"Inoculum effect on the efficacies of amoxicillin\u2010clavulanate, piperacillin\u2010tazobactam, and imipenem against extended\u2010spectrum beta\u2010lactamase (esbl)\u2010producing and non\u2010esbl\u2010producing Escherichia coli in an experimental murine sepsis model","volume":"57","author":"Docobo\u2010Perez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.00752-06","article-title":"Bactericidal activities of meropenem and ertapenem against extended\u2010spectrum\u2010beta\u2010lactamase\u2010producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model","volume":"51","author":"DeRyke","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib22","first-page":"3","article-title":"Clinical and molecular epidemiology of extended\u2010spectrum \u03b2\u2010lactamase\u2010producing Klebsiella pneumoniae and Escherichia coli in a Japanese tertiary hospital","volume":"2","author":"Harada","year":"2013","journal-title":"J Med Microb Diagn"},{"key":"10.1111\/1469-0691.12677_bib23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jac\/dkm371","article-title":"Peritoneal penetration of doripenem after intravenous administration in abdominal\u2010surgery patients","volume":"60","author":"Ikawa","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12677_bib24","first-page":"206","article-title":"Pharmacokinetic study of tazobactam\/piperacillin in experimental animals","volume":"42","author":"Maeda","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1111\/1469-0691.12677_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2796.2006.01641.x","article-title":"Clinical implications of hypermuco viscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community\u2010acquired bacteraemia","volume":"259","author":"Lee","year":"2006","journal-title":"J Intern Med"},{"key":"10.1111\/1469-0691.12677_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20030857","article-title":"A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications","volume":"199","author":"Fang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1111\/1469-0691.12677_bib27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/AAC.36.7.1577","article-title":"Stability of meropenem and effect of 1 beta\u2010methyl substitution on its stability in the presence of renal dehydropeptidase i","volume":"36","author":"Fukasawa","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/ajrcmb.24.1.4122","article-title":"Lipopolysaccharide induces mucus cell metaplasia in mouse lung","volume":"24","author":"Yanagihara","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/1469-0691.12677_bib29","series-title":"Rationale for the eucast clinical breakpoints, version 1.0. Piperacillin\u2010tazobactam","author":"EUCAST","year":"2010"},{"key":"10.1111\/1469-0691.12677_bib30","series-title":"Rationale for the eucast clinical breakpoints, version 1.5. Meropenem","author":"EUCAST","year":"2009"},{"key":"10.1111\/1469-0691.12677_bib31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.39.5.1187","article-title":"In vitro activities of various beta\u2010lactam antimicrobial agents against clinical isolates of Escherichia coli and klebsiella spp. Resistant to oxyimino cephalosporins","volume":"39","author":"Jett","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1198-743x.2001.x","article-title":"Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing shv extended\u2010spectrum beta\u2010lactamases","volume":"7","author":"Bedenic","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12677_bib33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkh462","article-title":"Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid\u2010mediated ampc\u2010type beta\u2010lactamase","volume":"54","author":"Kang","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12677_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/cid\/cis916","article-title":"Cefepime therapy for monomicrobial bacteremia caused by cefepime\u2010susceptible extended\u2010spectrum beta\u2010lactamase\u2010producing enterobacteriaceae: mic matters","volume":"56","author":"Lee","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12677_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of beta\u2010lactam antibiotics against Escherichia coli strains producing extended\u2010spectrum beta\u2010lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/46.3.461","article-title":"In vitro activities of parenteral beta\u2010lactam antimicrobials against tem\u201010\u2010, tem\u201026\u2010 and shv\u20105\u2010derived extended\u2010spectrum beta\u2010lactamases expressed in an isogenic Escherichia coli host","volume":"46","author":"Rebuck","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12677_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended\u2010spectrum beta\u2010lactamases: the ctx\u2010m enzymes","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","article-title":"Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin\u2010clavulanate and piperacillin\u2010tazobactam with extended\u2010spectrum beta\u2010lactamase\u2010producing and extended\u2010spectrum beta\u2010lactamase\u2010non\u2010producing Escherichia coli isolates","volume":"16","author":"Lopez\u2010Cerero","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12677_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1469-0691.2005.01184.x","article-title":"Hospital outbreak caused by a carbapenem\u2010resistant strain of Acinetobacter baumannii: patient prognosis and risk\u2010factors for colonisation and infection","volume":"11","author":"del Mar Tomas","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12677_bib40","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1128\/AAC.01483-06","article-title":"Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit\u2010endemic carbapenem\u2010resistant Pseudomonas aeruginosa strains in critically ill patients","volume":"51","author":"Pena","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12677_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1574884711308020005","article-title":"An evidence\u2010based review of risk\u2010reductive strategies for osteonecrosis of the jaws among cancer patients","volume":"8","author":"Kyrgidis","year":"2013","journal-title":"Curr Clin Pharmacol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14653350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:19:43Z","timestamp":1761117583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14653350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1198743X14653350"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12677","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/1469-0691.12677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}